Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LGALS3 (galectin-3): its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| lysosomal quality control | promotes | mechanism | 0.85 |
| cross-nucleation at damaged endolysosomal membranes | promotes | mechanism | 0.65 |
| amyloid plaque pathology | promotes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Aberrant Galectin-3 Expression on Stressed Synapses Creates | 0.610 | synaptic biology | What determines the selectivity of compl |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 3 hypotheses Top: 0.455
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.70 · 2026-04-12
closed · Rounds: 4 · Score: 0.53 · 2026-04-06
Hypotheses and analyses mentioning LGALS3 (galectin-3) in their description or question text
No additional research found